Mason P.  Slaine net worth and biography

Mason Slaine Biography and Net Worth

Director of Certara

Mr. Slaine is Chairman of the Board and investor in Cast & Crew and is a Board Member and investor in Reorg Inc and Certara LLC. He is also Executive Chairman of MLM2 and a principal investor in Varo Bank.

Most recently, Mr. Slaine was a Board member and investor in RS Energy, which was acquired by Genstar in February 2020 and Efront Holdings, which was acquired by BlackRock in May 2019. He was also Chairman and co-investor in FT Media Holdings, which was acquired by Gannett in 2018. Furthermore, Mr. Slaine was a Board Member and investor in IPAN GMBH, which was acquired by Castik Capital in June 2018 and Bureau Van Dijk, which was acquired by Moody’s Corporation in August 2017. From 2010 to 2015, Mr. Slaine was Executive Chairman of Interactive Data Corporation (IDC). IDC was acquired in December 2015 by The Intercontinental Exchange (ICE – NYSE).

Mr. Slaine was previously a principal owner and Board Member of iParadigms LLC. He was also Chairman, President and CEO as well as a principal investor in MLM Information Services, a leading SAS provider of corporate tax compliance software and services, which he co- founded in 2006 and sold in 2011 to Corporation Services Company (CSC). Prior to this role, Mr. Slaine was chairman and CEO of Information Holdings, a business he co-founded in 1997 and which was listed on the New York Stock Exchange from 1998- 2004. IHI was acquired by Thomson in 2004.

From 1994 to 1996, Mr. Slaine was President and CEO of Thomson Financial (now Thomson Reuters) and held various executive positions at Thomson from 1991 to 1993.  From 1987 to 1991, he was chairman and CEO of Securities Data Co until its acquisition by the Thomson Corporation.  From 1982 to 1986, Mr. Slaine was President and CEO, founder and a principal owner of Dealers Digest Inc., a financial information provider until its acquisition by Extel PLC.

Mr. Slaine holds an A.B., magna cum laude, from Amherst College and an MBA from Harvard University.

What is Mason P. Slaine's net worth?

The estimated net worth of Mason P. Slaine is at least $9.75 million as of August 16th, 2022. Mr. Slaine owns 910,322 shares of Certara stock worth more than $9,749,549 as of December 21st. This net worth approximation does not reflect any other investments that Mr. Slaine may own. Learn More about Mason P. Slaine's net worth.

How do I contact Mason P. Slaine?

The corporate mailing address for Mr. Slaine and other Certara executives is 100 OVERLOOK CENTER SUITE 101, PRINCETON NJ, 08540. Certara can also be reached via phone at 609-716-7900 and via email at [email protected]. Learn More on Mason P. Slaine's contact information.

Has Mason P. Slaine been buying or selling shares of Certara?

Mason P. Slaine has not been actively trading shares of Certara in the last ninety days. Most recently, Mason P. Slaine sold 182,475 shares of the business's stock in a transaction on Tuesday, August 16th. The shares were sold at an average price of $17.38, for a transaction totalling $3,171,415.50. Following the completion of the sale, the director now directly owns 910,322 shares of the company's stock, valued at $15,821,396.36. Learn More on Mason P. Slaine's trading history.

Who are Certara's active insiders?

Certara's insider roster includes Robert Aspbury (Insider), Eran Broshy (Director), James Cashman, III (Director), Jieun Choe (Insider), Justin Edge (Insider), William Feehery (CEO), Stephen McLean (Director), Leif Pedersen (Insider), Craig Rayner (Insider), Michael Schemick (CFO), Mason Slaine (Director), Patrick Smith (Insider), Richard Traynor (SVP), and Matthew Walsh (Director). Learn More on Certara's active insiders.

Are insiders buying or selling shares of Certara?

During the last year, insiders at the sold shares 6 times. They sold a total of 86,060 shares worth more than $1,151,075.18. The most recent insider tranaction occured on October, 7th when insider Patrick F Smith sold 5,409 shares worth more than $59,661.27. Insiders at Certara own 2.4% of the company. Learn More about insider trades at Certara.

Information on this page was last updated on 10/7/2024.

Mason P. Slaine Insider Trading History at Certara

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/16/2022Sell182,475$17.38$3,171,415.50910,322View SEC Filing Icon  
3/16/2022Sell125,000$20.17$2,521,250.00View SEC Filing Icon  
2/1/2022Sell50,000$26.61$1,330,500.00View SEC Filing Icon  
1/3/2022Sell50,000$28.63$1,431,500.00View SEC Filing Icon  
12/13/2021Sell50,000$28.05$1,402,500.00View SEC Filing Icon  
11/22/2021Sell376,149$29.74$11,186,671.26View SEC Filing Icon  
9/13/2021Sell620,668$29.80$18,495,906.40View SEC Filing Icon  
See Full Table

Mason P. Slaine Buying and Selling Activity at Certara

This chart shows Mason P Slaine's buying and selling at Certara by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Certara Company Overview

Certara logo
Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
Read More

Today's Range

Now: $10.71
Low: $10.51
High: $11.05

50 Day Range

MA: $10.81
Low: $9.55
High: $11.71

2 Week Range

Now: $10.71
Low: $9.41
High: $19.87

Volume

3,240,121 shs

Average Volume

852,739 shs

Market Capitalization

$1.72 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.53